| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $46.0M | +12.1% |
| Cost of Revenue | $53.4M | +23.9% |
| Gross Profit | -$7.4M | -255.1% |
| R&D Expense | $10.7M | -37.7% |
| SG&A Expense | $30.1M | -39.0% |
| Operating Income | -$54.9M | +33.3% |
| Pre-tax Income | -$71.2M | +2.8% |
| Income Tax | $117K | +685.0% |
| Net Income | -$71.4M | +2.6% |
| EPS (Basic) | -$4.33 | +25.0% |
| EPS (Diluted) | -$4.33 | +25.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $39.0M | +3118.9% |
| Accounts Receivable | $6.3M | +68.2% |
| Inventory | $27.1M | -45.8% |
| Current Assets | $80.1M | +38.8% |
| Total Assets | $105.3M | +18.1% |
| Current Liabilities | $33.8M | -11.0% |
| Long-term Debt | $31.0M | +417.5% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.3M | +16.4% |
| Capital Expenditures | $2.7M | — |
| Investing Cash Flow | -$2.7M | -135.0% |
| Financing Cash Flow | $67.8M | +4546.1% |
| Free Cash Flow | -$30.0M | +8.1% |
| $67.2M |
| +35.7% |
| Stockholders' Equity | $38.2M | -3.8% |